A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall.

(By Charles Ornstein, ProPublica, and Katie Thomas, The New York Times, May 31, 2017)

A company that manages prescription drug plans for tens of millions of Americans has sued a tiny drug maker that makes an emergency treatment for heroin and painkiller overdoses, increasing the tension between the companies that make drugs and those that decide whether they should be covered. Continue reading article here…

This article is a collaboration between ProPublica and The New York Times.

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

 

 

Leave a Reply